The decapeptide gonadotrophin-releasing hormone (GnRH) is now regarded as the sole hypothalamic product governing the release of the pituitary gonadotrophic hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH). After synthesis in the perikarya of hypothalamic neurons, GnRH is transported along axons to be stored in the nerve terminals of the median eminence region of the hypothalamus. GnRH release into hypophyseal-portal capillaries is effected by neurotransmitters of the central catecholaminergic system, originating in many brain areas 1,21. In males, the serum level of gonadotrophic hormones is under classical negative feedback control from gonadal steroids. However, in females, oestrogen feedback regulation of LH is both negative and positive, this latter being unique to the gonadotrophins and with no male counterpart. Rising serum oestrogen concentrations From the maturing ovarian follicle sensitize the gonadotroph to GnRH stimulation, with resultant augmentation of LH release during mid-cycle. The oestrogen-induced LH discharge is responsible for follicle rupture and ovulation, without which cyclical ovarian activity ceases and infertility ensues.
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Studies in vivo to define the precise site(s) of positive oestrogen feedback have largely been performed in intact subjects or animal models.
These are difficult to interpret singe oestrogen could act primarily either to modify hypoCorrespondence: Dr R. N. Clayton, Department of Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TH, U.K. thalamic GnRH secretion, or directly upon the pituitary gonadotroph to enhance its responsiveness to endogenous GnRH.
There is considerable evidence in vivo and in vitro for both inhibitory and stimulatory influences of gonadal steroids at the level of the pituitary gland. Much less information is available concerning sex steroid regulation of hypothalamic GnRH secretion in different physiological circumstances, since the peptide cannot be measured reliably in systemic serum samples. However, from measurements of GnRH in blood collected from the pituitary stalk of animals, a technically difficult approach, evidence is emerging that tonic negative feedback of gonadotrophin secretion could operate at the level of the hypothalamus [3, 41. Cyclical oestrogen augmentation of LH release might also be mediated, at least in part, by its stimulation of endogenous GnRH release, at least in some species 151.
However, in primates the major site for oestrogen positive feedback is probably the pituitary itself. When endogenous GnRH secretion is eliminated by destructive lesions of the hypothalamic median eminence, gonadotrophin release and cyclical ovarian activity promptly ceases. Cyclical ovarian steroid secretion and pre-ovulatory serum LH surges, identical with those of a spontaneous cycle, as well as ovulation, can be restored by a regimen of unvarying exogenous GnRH administration [6,71. Thus, the primate menstrual cycle can be generated by ovarian steroids acting solely upon the anterior pituitary with hypothalamic GnRH secretion serving an essential permissive, rather than primary regulatory, role. Convincing though these elegant studies appear, they do not exclude oestrogen amplification of endogenous GnRH secretion in the intact primate. Much research effort has been applied to further our knowledge of the hormonal regulation of the menstrual cycle, with the implication that a greater understanding might lead to improved and safer methods for its interruption. In the last few years the physiological significance of pituitary exposure to intermittent, rather than continuous, stimulation by GnRH has been appreciated [ 6 ] . It has now been clearly shown that continuous administration of GnRH [lo], or even intermittent exposure to high doses, especially of the long-acting agonist analogues I 1 11, causes a progressive reduction in pituitary gonadotrophin output. This pituitary refractoriness, or desensitization, applies to many species, and also to cultured pituitary cells in vitro [121. The therapeutic implications of these observations are discussed later in this review.
Mechanism of GnRH action
The subcellular mechanism(s) through which the feedback influences of gonadal steroid hormones might operate upon pituitary responsiveness to GnRH are unclear. Despite much research over the last 10 years, consensus has only been reached on the first and last steps in the process of LH release following GnRH stimulation.
In common with many other small peptide and glycoprotein hormones, GnRH initiates its effects following interaction with specific receptors in the gonadotroph surface membrane 11 31.
Following hormone receptor binding a series of plasma membrane-related events occur which ultimately lead to LH secretion. and probably also synthesis ( Recently, it has been shown that the LH release process is independent of cellular internalization of GnRH-receptor complexes by the gonadotroph [211. Although none of these many biochemical subcellular events, with the exception of CaZ+ mobilization, is directly linked to the release of preformed LH, their participation in such cellular processes as hormone synthesis, packaging and movement of storage granules is not precluded.
It is evident that hormonal modulation of GnRH action could operate through alterations in any or all of these intracellular processes, either singly or in combination. While the rodent oestrous cycle provides one example of a positive correlation between pituitary GnRH receptor concentration and enhanced pituitary responsiveness to GnRH. another is evident following gonadectomy. In both male and female rats. a rapid doubling of GnRH receptor concentration occurs following removal of gonadal steroid feedback (Table 2) Further evidence for the regulatory role of gonadal steroids on GnRH receptor concentration is provided by their analysis during sexual maturation. In male animals there is an inverse correlation between GnRH receptor values and the serum concentrations of testosterone (Table 2) 
General principles of hormone action and therapeutic implications
The GnRH-pituitary gonadotroph system highlights several important principles in hormone action, which are directly relevant to their therapeutic usage.
Intermittent exposure of the gonadotroph to GnRH may induce receptors and amplify cellular responsiveness to subsequent stimulation. However, the ligand-inducing effect upon its receptors spans a narrow dose range above which the opposite effect of receptor 'down-regulation' and cell refractoriness is observed. This latter may represent a generalized cellular mechanism to restrict the effects of excessive stimulation. Thus, modification of the initial step of hormone action on a target cell forms an important regulatory mechanism in determining tissue responsiveness.
For long-term stimulation of gonadotrophin secretion, GnRH must be administered in low doses and with a frequency similar to that occurring naturally. In this manner low-dose pulses of GnRH, given 2-hourly, restore full gonadal function in patients with absence of endogenous GnRH secretion 138-411. As in the hypothalamic-lesioned monkey 161, serum gonadotrophin and sex steroid profiles were strikingly similar to those of spontaneous menstrual cycles 1391 and the pattern seen during the peri-pubertal maturation of the pituitarygonadal axis 1381. Prolonged pulsatile GnRH therapy can also induce normal spermatogenesis and fertility in males in selected instances.
The practical problems of GnRH delivery for long-term treatment have been overcome by the ingenious conversion of light-weight motor driven syringes programmed to expel intermittent pulses of GnRH via subcutaneously or intravenously sited cannulae.
The desensitizing property of high-dose, frequent, administration of the long-acting GnRH agonist analogues can also be employed where suppression of gonadal activity is desired. In such circumstances the development of nasal sprays containing 'slow-release' formulations of the peptides are an obvious advance for patient compliance. By the nasal route long-acting GnRH analogues can successfully abolish menses and ovulation 1111, though the reliability and suitability of this approach for widespread contraceptive usage remains to be determined. In males, spermatogenesis can be suppressed 1421, but only at the expense of markedly reduced serum testosterone levels, with a concomitant unacceptable decrease in libido and potency. A 'medical' gonadectomy might be an acceptable alternative to surgery in the treatment of hormone-dependent tumours, e.g. mammary and prostatic carcinomas. Dramatic clinical and hormonal remission can be achieved by GnRH analogue treatment of true precocious puberty [431. Other potential antigonadal therapeutic applications of long-acting GnRH analogues are in endometriosis and for severe premenstrual tension. It appears, therefore, that the paradoxical antifertility properties of GnRH peptides will have greater clinical application than the pro-fertility ones for which they were originally intended. A further important advantage of the antifertility property of GnRH analogues is its rapid reversibility [441 and freedom from long-term side effects.
